Pages that link to "Q51938027"

The following pages link to Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia (Q51938027):

Displaying 34 items.

• Negative affective states and cognitive impairments in nicotine dependence (Q30371220) (← links)
• Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia (Q30428422) (← links)
• Working memory deficits predict short-term smoking resumption following brief abstinence (Q33625059) (← links)
• Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance (Q33635728) (← links)
• Predictors of early abstinence in smokers with schizophrenia (Q33679772) (← links)
• Chronic Cigarette Smoking: Implications for Neurocognition and Brain Neurobiology (Q33765602) (← links)
• Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function (Q33897781) (← links)
• Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness (Q33946959) (← links)
• Proactive outreach for smokers using VHA mental health clinics: protocol for a patient-randomized clinical trial (Q34995215) (← links)
• Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats. (Q35889304) (← links)
• Treatment of tobacco dependence in mental health and addictive disorders (Q36783506) (← links)
• Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development (Q36935148) (← links)
• The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues (Q36965847) (← links)
• Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment (Q37188764) (← links)
• Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia (Q37268687) (← links)
• Association of abstinence-induced alterations in working memory function and COMT genotype in smokers (Q37341565) (← links)
• Effect of COMT Val(158)Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia (Q37693831) (← links)
• Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status (Q37693834) (← links)
• A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia (Q37962995) (← links)
• Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls (Q39702017) (← links)
• Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls (Q43795883) (← links)
• Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice (Q46829706) (← links)
• Tobacco and schizophrenia: therapeutic aspects (Q46886196) (← links)
• The effects of cigarette smoking behavior and psychosis history on general and social cognition in bipolar disorder (Q47383060) (← links)
• Sleep as a Target for Optimized Response to Smoking Cessation Treatment (Q47669063) (← links)
• Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy. (Q47778615) (← links)
• Does self-control modify the impact of interventions to change alcohol, tobacco, and food consumption? A systematic review (Q48510046) (← links)
• Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia (Q51030618) (← links)
• Not All Differences between Patients with Schizophrenia and Healthy Subjects Are Pathological: Performance on the Conners' Continuous Performance Test. (Q51813550) (← links)
• The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls (Q80178742) (← links)
• Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence (Q89136909) (← links)
• Review of pharmacotherapy for smoking cessation in patients with schizophrenia (Q89330753) (← links)
• Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial (Q89626139) (← links)
• Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation (Q94365066) (← links)